These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26377413)

  • 1. Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.
    Lund SH; Aspelund T; Kirby P; Russell G; Einarsson S; Palsson O; Stefánsson E
    Br J Ophthalmol; 2016 May; 100(5):683-7. PubMed ID: 26377413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diabetic Retinopathy Screening Tool for Low-Income Adults in Mexico.
    Mendoza-Herrera K; Quezada AD; Pedroza-Tobías A; Hernández-Alcaraz C; Fromow-Guerra J; Barquera S
    Prev Chronic Dis; 2017 Oct; 14():E95. PubMed ID: 29023230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
    Aspelund T; Thornórisdóttir O; Olafsdottir E; Gudmundsdottir A; Einarsdóttir AB; Mehlsen J; Einarsson S; Pálsson O; Einarsson G; Bek T; Stefánsson E
    Diabetologia; 2011 Oct; 54(10):2525-32. PubMed ID: 21792613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
    Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
    Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
    Soto-Pedre E; Pinies JA; Hernaez-Ortega MC
    J Diabetes Complications; 2015; 29(4):508-11. PubMed ID: 25725582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.
    Walton OB; Garoon RB; Weng CY; Gross J; Young AK; Camero KA; Jin H; Carvounis PE; Coffee RE; Chu YI
    JAMA Ophthalmol; 2016 Feb; 134(2):204-9. PubMed ID: 26720694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders.
    Tufail A; Rudisill C; Egan C; Kapetanakis VV; Salas-Vega S; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Srinivas S; Nittala M; Sadda S; Taylor P; Rudnicka AR
    Ophthalmology; 2017 Mar; 124(3):343-351. PubMed ID: 28024825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
    Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
    J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
    Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
    BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
    Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
    Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.
    Swanson M
    Optometry; 2005 Nov; 76(11):636-46. PubMed ID: 16298316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England.
    Jones CD; Greenwood RH; Misra A; Bachmann MO
    Diabetes Care; 2012 Mar; 35(3):592-6. PubMed ID: 22279031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
    Olafsdóttir E; Stefánsson E
    Br J Ophthalmol; 2007 Dec; 91(12):1599-601. PubMed ID: 17627978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Groeneveld Y; Tavenier D; Blom JW; Polak BCP
    Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
    Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
    PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.
    van der Heijden AA; Abramoff MD; Verbraak F; van Hecke MV; Liem A; Nijpels G
    Acta Ophthalmol; 2018 Feb; 96(1):63-68. PubMed ID: 29178249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading and disease management in national screening for diabetic retinopathy in England and Wales.
    Harding S; Greenwood R; Aldington S; Gibson J; Owens D; Taylor R; Kohner E; Scanlon P; Leese G;
    Diabet Med; 2003 Dec; 20(12):965-71. PubMed ID: 14632697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.